Geode Capital Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $913K | Sell |
|
|||||
|
2025
Q1 | $2.37M | Buy |
|
|||||
|
2024
Q4 | $2.65M | Buy |
|
|||||
|
2024
Q3 | $5.55M | Buy |
|
|||||
|
2024
Q2 | $5.82M | Sell |
|
|||||
|
2024
Q1 | $8.96M | Buy |
|
|||||
|
2023
Q4 | $7.64M | Buy |
|
|||||
|
2023
Q3 | $5.38M | Buy |
|
|||||
|
2023
Q2 | $10.7M | Buy |
|
|||||
|
2023
Q1 | $7.52M | Buy |
|
|||||
|
2022
Q4 | $10.6M | Buy |
|
|||||
|
2022
Q3 | $21.6M | Buy |
|
|||||
|
2022
Q2 | $12.2M | Buy |
|
|||||
|
2022
Q1 | $7.34M | Buy |
|
|||||
|
2021
Q4 | $4.32M | Buy |
|
|||||
|
2021
Q3 | $7.87M | Buy |
|
|||||
|
2021
Q2 | $2.83M | Buy |
|